Communiqués Balchem Corporation

Actions

BCPC

US0576652004

Chimie de spécialité

Marché Fermé - Nasdaq 22:00:00 10/09/2026			Varia. 5j.	Varia. 1 janv.
166,67 ^USD	-0,99%		-2,95%	+8,68%

31/07	Transcript : Balchem Corporation, Q2 2026 Earnings Call, Jul 31, 2026
31/07	Balchem Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

09/09	Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026	GL
31/07	Balchem Corporation Reports Second Quarter 2026 Financial Results	GL
17/07	Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026	GL
26/06	Balchem : to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026	PU
26/06	Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026	GL
27/05	Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026	GL
08/05	MSM for Knee Health Study: Clinical Research Supporting Knee Comfort and Quality of Life with OptiMSM®	PU
01/05	Balchem : Announces Global Price Increase for Animal Nutrition and Health Products	PU
30/04	Balchem : Reports First Quarter 2026 Financial Results	PU
30/04	Balchem Corporation Reports First Quarter 2026 Financial Results	GL
22/04	Balchem : Releases 2025 Sustainability Report	PU
22/04	Balchem Corporation Releases 2025 Sustainability Report	GL
21/04	Balchem : How Vitamin K2 MK‑7 May Support Neuromuscular Signaling in Older Adults	PU
16/04	Balchem : Thailand FDA Approval of OptiMSM® Expands Innovation Opportunities	PU
16/04	How VitaCholine® Supports Brain Health In Menopause: New Research On Working Memory And Brain Activation	PU
16/04	Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026	GL
03/04	Why Supplement Quality Matters: Insights from The Supplement Source Podcast and the K2 Case Study	PU
02/04	Balchem : New Clinical Study Uncovers Potential K2VITAL™ Post-Exercise Neuromuscular Signaling in Older Adults	PU
09/03	Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops	GL
25/02	Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026	GL
25/02	Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026	AQ
24/02	Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026	GL
24/02	Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026	AQ
20/02	Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results	GL
09/02	Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026	AQ